# A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

> **NCT04018378** · PHASE1 · COMPLETED · sponsor: **Korea University Anam Hospital** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** varenicline tartrate 1mg (HGP1604, R) - varenicline oxalate 1mg (HIP1502, T), RT
- **DRUG:** varenicline oxalate 1mg (HIP1502, T) - varenicline tartrate 1mg (HGP1604, R), TR

## Key facts

- **NCT ID:** NCT04018378
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-06
- **Primary completion:** 2017-05-15
- **Final completion:** 2018-09-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04018378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04018378, "A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04018378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*